Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $7,418 | 382 | 98.7% |
| Education | $95.55 | 3 | 1.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| PFIZER INC. | $1,410 | 59 | $0 (2024) |
| Lilly USA, LLC | $915.40 | 47 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $879.84 | 57 | $0 (2024) |
| ABBVIE INC. | $704.84 | 40 | $0 (2024) |
| Novo Nordisk Inc | $551.68 | 32 | $0 (2023) |
| Bayer Healthcare Pharmaceuticals Inc. | $534.02 | 19 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $277.01 | 12 | $0 (2022) |
| Allergan, Inc. | $272.12 | 15 | $0 (2021) |
| Novartis Pharmaceuticals Corporation | $237.12 | 15 | $0 (2019) |
| Vanda Pharmaceuticals Inc. | $201.24 | 7 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $676.92 | 34 | Lilly USA, LLC ($172.31) |
| 2023 | $827.02 | 40 | Lilly USA, LLC ($254.36) |
| 2022 | $1,065 | 49 | Bayer HealthCare Pharmaceuticals Inc. ($256.96) |
| 2021 | $1,217 | 62 | AbbVie Inc. ($259.78) |
| 2020 | $795.00 | 42 | PFIZER INC. ($280.85) |
| 2019 | $814.63 | 45 | PFIZER INC. ($180.73) |
| 2018 | $869.69 | 49 | AstraZeneca Pharmaceuticals LP ($144.61) |
| 2017 | $1,248 | 64 | PFIZER INC. ($391.02) |
All Payment Transactions
385 individual payment records from CMS Open Payments — Page 1 of 16
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/26/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $22.81 | General |
| Category: Oncology | ||||||
| 11/21/2024 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY, ABRYSVO | Food and Beverage | In-kind items and services | $24.62 | General |
| Category: VACCINES | ||||||
| 11/20/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $17.56 | General |
| Category: RESPIRATORY | ||||||
| 10/29/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $25.00 | General |
| Category: DIABETES | ||||||
| 10/24/2024 | ABBVIE INC. | LINZESS (Drug) | Food and Beverage | In-kind items and services | $20.03 | General |
| Category: GASTROENTEROLOGY | ||||||
| 10/22/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug), AIRSUPRA | Food and Beverage | In-kind items and services | $18.07 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 10/02/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $13.89 | General |
| Category: Cardio-renal | ||||||
| 09/17/2024 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY, ABRYSVO | Food and Beverage | In-kind items and services | $25.96 | General |
| Category: VACCINES | ||||||
| 09/05/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $24.49 | General |
| Category: Diabetes | ||||||
| 08/29/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $15.50 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 08/02/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $23.49 | General |
| Category: Diabetes | ||||||
| 07/23/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $14.75 | General |
| Category: Respiratory | ||||||
| 07/10/2024 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY, ABRYSVO | Food and Beverage | In-kind items and services | $24.78 | General |
| Category: VACCINES | ||||||
| 06/27/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $20.13 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 06/25/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $25.19 | General |
| Category: Oncology | ||||||
| 06/13/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $27.08 | General |
| Category: Diabetes | ||||||
| 06/13/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $1.00 | General |
| Category: Diabetes | ||||||
| 06/06/2024 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY, ABRYSVO | Food and Beverage | In-kind items and services | $29.40 | General |
| Category: VACCINES | ||||||
| 06/05/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $19.07 | General |
| Category: Diabetes | ||||||
| 05/16/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $9.41 | General |
| Category: Diabetes | ||||||
| 05/14/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $14.85 | General |
| Category: Respiratory | ||||||
| 05/02/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $18.11 | General |
| Category: PSYCHIATRY | ||||||
| 05/02/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), AREXVY | Food and Beverage | In-kind items and services | $16.07 | General |
| Category: RESPIRATORY | ||||||
| 04/30/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $25.82 | General |
| Category: Diabetes | ||||||
| 04/23/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $16.06 | General |
| Category: Respiratory | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 5 | 440 | 1,081 | $203,049 | $78,602 |
| 2022 | 5 | 531 | 1,479 | $267,265 | $101,008 |
| 2021 | 6 | 453 | 1,247 | $202,180 | $86,484 |
| 2020 | 7 | 636 | 1,631 | $268,205 | $110,577 |
All Medicare Procedures & Services
23 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 181 | 694 | $119,414 | $45,880 | 38.4% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 99 | 120 | $31,200 | $13,013 | 41.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 55 | 145 | $25,375 | $9,369 | 36.9% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2023 | 73 | 90 | $18,900 | $6,057 | 32.0% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 32 | 32 | $8,160 | $4,283 | 52.5% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 198 | 930 | $159,570 | $55,125 | 34.5% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 128 | 168 | $43,667 | $18,963 | 43.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 63 | 203 | $26,573 | $12,902 | 48.6% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2022 | 100 | 136 | $28,545 | $8,195 | 28.7% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 42 | 42 | $8,910 | $5,823 | 65.3% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 145 | 715 | $112,300 | $43,551 | 38.8% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2021 | 96 | 134 | $33,124 | $15,347 | 46.3% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 78 | 226 | $26,216 | $15,152 | 57.8% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2021 | 77 | 115 | $22,425 | $6,979 | 31.1% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 36 | 36 | $7,380 | $5,078 | 68.8% |
| G0008 | Administration of influenza virus vaccine | Office | 2021 | 21 | 21 | $735.00 | $376.74 | 51.3% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 196 | 884 | $138,788 | $54,206 | 39.1% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2020 | 142 | 207 | $51,039 | $24,152 | 47.3% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 87 | 266 | $30,856 | $15,748 | 51.0% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2020 | 129 | 192 | $37,440 | $11,914 | 31.8% |
| 99236 | Hospital observation or inpatient care high severity, 55 minutes per day | Facility | 2020 | 18 | 18 | $7,812 | $3,373 | 43.2% |
| G0008 | Administration of influenza virus vaccine | Office | 2020 | 36 | 36 | $1,260 | $636.13 | 50.5% |
| 90686 | Vaccine for influenza for administration into muscle, 0.5 ml dosage | Office | 2020 | 28 | 28 | $1,010 | $548.24 | 54.3% |
About Dr. Syed Moeed, M.D
Dr. Syed Moeed, M.D is a Internal Medicine healthcare provider based in Evergreen Park, Illinois. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/07/2006. The National Provider Identifier (NPI) number assigned to this provider is 1255371498.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Syed Moeed, M.D has received a total of $7,514 in payments from pharmaceutical and medical device companies, with $676.92 received in 2024. These payments were reported across 385 transactions from 29 companies. The most common payment nature is "Food and Beverage" ($7,418).
As a Medicare-enrolled provider, Moeed has provided services to 2,060 Medicare beneficiaries, totaling 5,438 services with total Medicare billing of $376,672. Data is available for 4 years (2020–2023), covering 23 distinct procedure/service records.
Practice Information
- Specialty Internal Medicine
- Location Evergreen Park, IL
- Active Since 06/07/2006
- Last Updated 10/14/2021
- Taxonomy Code 207R00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1255371498
Products in Payments
- MOUNJARO (Drug) $539.00
- Kerendia (Drug) $534.02
- CHANTIX (Drug) $514.98
- ELIQUIS (Drug) $373.56
- XARELTO (Drug) $277.01
- LYRICA (Drug) $270.60
- JARDIANCE (Drug) $268.25
- ENTRESTO (Drug) $237.12
- SYMBICORT (Drug) $230.27
- FARXIGA (Drug) $217.43
- VRAYLAR (Drug) $215.23
- HETLIOZ (Drug) $201.24
- TRULICITY (Drug) $190.13
- BREZTRI (Drug) $187.54
- UBRELVY (Drug) $183.47
- Ozempic (Drug) $164.24
- LINZESS (Drug) $162.79
- Victoza (Drug) $161.52
- PREVNAR 20 (Biological) $152.79
- Creon (Drug) $149.30
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Evergreen Park
Dr. Abdallah Altarshan, Md, MD
Internal Medicine — Payments: $232,323
Dr. Mohammad Tarek Kabbany, M.d, M.D
Internal Medicine — Payments: $19,253
Mohammad Razzaque, M.d, M.D
Internal Medicine — Payments: $6,592
Satwant Kingra, Md, MD
Internal Medicine — Payments: $5,760
Dr. Hamdi Khilfeh, M.d, M.D
Internal Medicine — Payments: $5,168
Syed Mohsin, M.d, M.D
Internal Medicine — Payments: $4,460